Thomas Glanzmann

Thomas Glanzmann is the chief executive officer of Grifols. He previously worked at Madison Dearborn Partners as a Member of Healthcare Advisory Board.

Currently, Thomas is Vice Chairman of Grifols SA and the Chairman of the Grifols Sustainability Committee. He is also a Board member of Alcon Inc., where he ...

In April 2024, he transitioned the CEO position to Nacho Abia and became non-Executive Chairman in September. During his long tenure, first as a ...

Thomas Glanzmann joined the Sulzer Board of Directors in 2012. Previously, he was. CEO and President of the Swedish company Gambro (2006 to 2011) and CEO and.

Thomas Glanzmann, the executive who landed at the helm of Grifols to lead the pharmaceutical company for two years – a period in which he ...

Ort: Wollerau · 500+ Kontakte auf LinkedIn. Sehen Sie sich das Profil von Thomas Glanzmann Thomas Glanzmann auf LinkedIn, einer professionellen Community ...

Thomas Glanzmann will become non-executive Chairman of the Board of Directors, and that CEO Nacho Abia will assume all executive responsibilities.

Thomas Glanzmann has decided not to stand for reelection at the 2025 annual general meeting (AGM) after concluding his two-year agreement to act as Executive ...

Thomas Glanzmann, a venture capital investor with Medtech Ventures Partners where he evaluates and invests in medical device companies, brings strategic insights and financial and risk management experience to the Board, as well as his decades long experience in the healthcare industry.

Thomas Glanzmann is the Founder and has been a Partner at Medtech Ventures Partners since 2017. He currently is the Non-Executive Chairman of Grifols SA.

Grifols SA has accelerated a plan to cut Chairman Thomas Glanzmann's executive powers as the Spanish drugmaker seeks to bolster its corporate governance.